{"data":{"id":"us/21-cfr-357.152","jurisdiction":"us","citation":"21 CFR 357.152","heading":"Package inserts for anthelmintic drug products.","body":"The labeling of the product contains a consumer package insert which includes the following information:\n(a) A discussion of the symptoms suggestive of pinworm infestation, including a statement that pinworms must be visually identified before taking this medication.\n(b) A detailed description of how to find and identify the pinworm.\n(c) A commentary on the life cycle of the pinworm.\n(d) A commentary on the ways in which pinworms may be spread from person to person and hygienic procedures to follow to avoid such spreading.\n(e) The appropriate labeling information contained in § 357.150","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER D—DRUGS FOR HUMAN USE","PART 357—MISCELLANEOUS INTERNAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE","Subpart B—Anthelmintic Drug Products"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"fc32a9401c6690275e946e819008ce9cb86825b8f7d6ed3da2bb7950e66d7e8a","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-357.150","next":"us/21-cfr-357.180"},"notice":"GroundRules: Original legal text. Not legal advice."}